Comments on: Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR) https://thegbm.com/novartis-cosentyx-becomes-first-and-only-fda-approved-anti-il-17-biologic-for-people-with-polymyalgia-rheumatica-pmr/ Business news, opinion, reviews, interviews Tue, 17 Nov 2026 02:43:00 +0000 hourly 1 https://wordpress.org/?v=7.1.4